News

Mucosal-associated invariant T (MAIT) cells don't obey the usual immune cell rules, and new research has revealed another "superpower" of this cell type.

A significant breakthrough in developing a passive radiative cooling (PRC) material has been announced by researchers at City University of Hong Kong (CityU).

When scientists examined pellets from recycled plastic collected in 13 countries they found hundreds of toxic chemicals, including pesticides and pharmaceuticals.

Researchers describes a hitherto unknown protein with anti-oxidizing properties secreted by Coxiella burnetii, a Gram-negative intracellular bacterium, pointing to possible treatments for auto-immune diseases and even cancer.

In 2021, a University-led research team received a contract worth up to $33 million to develop an implantable “living pharmacy” to control the human body’s sleep/wake cycles. Now, the researchers have completed a major step toward achieving this.

Scientists have developed a new method to engineer more powerful immune cells that can potentially be used for “off-the-shelf” cell therapy to treat challenging cancers.

Vaccinating both girls and boys against HPV is the best way to prevent cervical cancer, reports a new study. Gender-neutral vaccination induces herd immunity that will help to eradicate cancer-causing virus types.

The Synthetic Yeast Genome Project 2.0 declares a major milestone: it has created a yeast strain comprising over 50% synthetic DNA.

A University of Alberta team has developed a new step to improve the process for creating insulin-producing pancreatic cells from a patient’s own stem cells, bringing the prospect of injection-free treatment closer for people with diabetes.

Studying the evolutionary history of influenza viruses to quantitatively analyze how they evolved may help predict future strains and guide vaccine development.